Novavax Inc., one of the front-runners in the race to develop a COVID-19 vaccine, will receive $1.6 billion from the U.S. government, the biggest contribution yet from the Operation Warp Speed program. The funds will allow the company to conduct advanced human studies and establish manufacturing to deliver 100 million doses as soon as late 2020, Gaithersburg, Md.-based Novavax said in a statement. Shares of Novavax rose as much as 41%, the highest since September 2016, in Tuesday trading. Novavax is among companies striving to develop an inoculation against the novel coronavirus that’s spreading quickly in countries including the U.S., India and Mexico. President Donald Trump’s Warp Speed...
Full ArticleU.S. pumps $1.6 billion into Novavax’s COVID vaccine development
WorldNews
0 shares
1 views
You might like
Related news coverage
Nvidia & darpa biohybrid
Rumble
https://www.youtube.com/watch?v=0Hg7XhbXuac . No One is Talking About What Just Happened..
Is Coronavirus Vaccine Made From Fetal Cell Lines?
Eurasia Review
US sinks another $2.1 billion into a potential vaccine
SeattlePI.com
Advertisement
More coverage
Study: Preventing Next Pandemic Will Cost More Than $22 Billion A Year
Newsy
Watch VideoA new study estimates it will cost tens of billions of dollars a year to prevent the next global..